Loading provider…
Loading provider…
Hematology & Oncology Physician in Antioch, CA
NPI: 1023174380Primary Practice Location
Epic Care
4721 Dallas Ranch Rd, Antioch, CA
Primary Employer
Epic Care
epic-care.com
HQ Phone
Get MD Prasad's Phone NumberMobile
Get MD Prasad's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardCA State Medical License
CA State Medical License
2011 - 2027
PA State Medical License
2008 - 2011

American Board of Internal Medicine
Hematology

American Board of Internal Medicine
Medical Oncology
Drexel University College of Medicine/Hahnemann University Hospital
Fellowship • Hematology and Medical Oncology
2008 - 2011
Pennsylvania Hospital of the University of Pennsylvania Health System
Residency • Internal Medicine
2005 - 2008
Karnatak Institute of Medical Sciences
MD • General Medicine
1998 - 2001
Coimbatore Medical College
Medical School
Until 1998
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99214Established patient office or other outpatient visit, 30-39 minutes | 190 | 442 |
| 2 | 85025Complete blood cell count (red cells, white blood cell, platelets), automated test | 189 | 707 |
| 3 | 36415Insertion of needle into vein for collection of blood sample | 174 | 613 |
| 4 | 99215Established patient office or other outpatient, visit typically 40 minutes | 65 | 110 |
| 5 | 96372Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | 64 | 324 |
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI)
Intervention / Treatment: OTHER: placebo, DRUG: tamoxifen citrate, DRUG: everolimus, DRUG: anastrozole, DRUG: exemestane, DRUG: letrozole, DRUG: goserelin acetate, DRUG: leuprolide acetate
Lead Sponsor: SWOG Cancer Research Network
Collaborators: National Cancer Institute (NCI), Millennium Pharmaceuticals, Inc.
Intervention / Treatment: DRUG: Bicalutamide, DRUG: TAK-700